Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension of AC-055-310, a Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™

NCT02112487 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT02112487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension of AC-055-310, a Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2014
Completion date
September 19, 2018
Enrollment
88 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension